Literature DB >> 2645436

The metabolic evaluation of patients with recurrent nephrolithiasis: a review of comprehensive and simplified approaches.

G M Preminger1.   

Abstract

The advent of percutaneous nephrostolithotomy and extracorporeal shock wave lithotripsy has definitely altered the way in which symptomatic renal calculi are approached. However, these new techniques should not affect the need for appropriate diagnostic evaluation and institution of medical treatment for the prevention of recurrent nephrolithiasis. A diagnostic evaluation should identify underlying physiological and environmental defects responsible for stone formation, as well as identify specific medical disorders that cause recurrent stone formation. With this information one then can construct an appropriate treatment program that will prevent the occurrence of additional calculi. Comprehensive metabolic protocols have evolved from tedious inpatient procedures to more convenient outpatient tests that can be performed in approximately 2 weeks. In addition, the advent of automated urinalysis packages has allowed many physicians access to reliable, sophisticated technology. Further dissemination of these simplified metabolic protocols will enable more accurate diagnosis of recurrent stone disease and, hopefully, permit the institution of appropriate medical therapy by a wider group of treating physicians.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645436     DOI: 10.1016/s0022-5347(17)41004-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Hypercalcemic States associated with nephrolithiasis.

Authors:  Brandon L Craven; Corey Passman; Dean G Assimos
Journal:  Rev Urol       Date:  2008

2.  The top 10 things nephrologists wish every primary care physician knew.

Authors:  Neil M Paige; Glenn T Nagami
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

3.  Oxalate status in stone-formers. Two distinct hyperoxaluric entities.

Authors:  M Hatch
Journal:  Urol Res       Date:  1993-01

4.  Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone disease.

Authors:  F Kokot; D Klimek; A Wiecek; M Kuczera
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Management of Clinically Insignificant Residual Fragments following Shock Wave Lithotripsy.

Authors:  Elisa Cicerello; Franco Merlo; Luigi Maccatrozzo
Journal:  Adv Urol       Date:  2012-05-31

6.  LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.

Authors:  Martino Marangella; Michele Petrarulo; Corrado Vitale; Piergiuseppe Daniele; Silvio Sammartano
Journal:  Urolithiasis       Date:  2020-11-27       Impact factor: 3.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.